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Abstract
Objective: Currently 1/12 of the world’s population has diabetes mellitus (DM), many are or will be screened by
having retinal images taken. This current study aims to compare the DAPHNE software’s ability to detect DR in three
different European populations compared to human grading carried out at the Moorfields Eye Hospital Reading
Centre (MEHRC).
Participants: Retinal images were taken from participants of the HAPIEE study (Lithuania, n=1014), the PAMDI
study (Italy, n=882) and the MARS study (Germany, n=909).
Methods: All anonymized images were graded by human graders at MEHRC for the presence of DR.
Independently, and without any knowledge of the human grader’s results, the DAPHNE software analysed the
images and divided the participants into DR and no-DR groups.
Main outcome measures: The primary outcomes were sensitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV) of the DAPHNE software with regards to the identification of DR or no-DR on retinal
images as compared to the human grader as reference standard.
Results: A total of 2805 participants were enrolled from the three study sites. The sensitivity of the DAPHNE
software was above 93% in all three studies specificity was above 80%, the PPV was above 28% and the NPV was
not below 98.8% in any of the studies. The DAPHNE software did not miss any vision-threatening DR. The areas
under the curve (AUC) for all three studies were above 0.96. DAPHNE reduced manual human workload by 70% but
had a total false positive rate of 63%.
Conclusions: The DAPHNE software showed to be reliable to detect DR on three different European
populations, using three different imaging settings. Further testing is required to see scalability, performance on live
DR screening systems and on camera settings different to these studies.
Keywords: Diabetic retinopathy; Automated grading; Europe;
Diabetic retinopathy screening; Diabetes
Introduction
Worldwide, the number of patients with Diabetes Mellitus (DM) is
expected to increase from 177 million in 2000 to 366 million by 2030
[1] while the International Diabetes Federation (IDF) estimates as
many as 592 million with DM by 2035. Currently, about 1/12 of the
world’s population has DM [2]. Detection of Diabetic Retinopathy
(DR) relies on detailed examination of the retina either using a slit-
lamp eye examination method or analysis of fundus images. This latter
one is usually done by human graders; let it be in population based
studies or in DR screening programmes. Due to the increase of
imaging volume, it might not be possible to keep up with the grading
demands and new solutions, such as automated image analysis, might
be a viable option to safely and effectively analyse image sets. In many
countries current recommendation is to screen for DR in patients with
DM annually. In the publicly funded UK system about 80% of the
eligible DM patients are screened annually [3], and as a results of the
screening programme, DR is no longer the leading cause of blindness
in working-age population [4]. Population based studies also generate
large image sets, and the analysis of these is crucial for understanding
trends in disease detection and progression and to inform policy in the
relevant countries. With the advent of portable imaging technologies,
the amount of retinal imaging generated is likely to increase
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exponentially. Automated detection software could be one way to
minimise the impact of this increasing workload, allowing healthcare
provider to focus on those patients requiring treatment.
Automated detection software has proved to be reliable in earlier
studies [5,6], but there is a need to establish if these softwares work
equally well in different populations and on different imaging
modalities. Earlier studies mainly focused on smaller samples from one
population group [7-9]. Therefore there is a need for further testing
and analysis on larger samples and different population groups, and
compare the results to human graders’ results on the same images. In
the DR screening programmes, about 2/3rd of the patients have no DR
and grading the images from these patients takes the attention away
from those requiring quick turnaround in grading and timely referral.
Therefore it is imperative that any automated software has excellent
ability to detect no DR and is very reliable in this area, so no or
minimal re-grading by human graders is required for those images
with no-DR. Our aim in this study is to test the automated software’s
(named DAPHNE [10] ability to detect or rule out DR on 3 different
population samples generated in different parts of Europe. In order to
achieve our goal, we used three population based studies as we set out
to test DAPHNE’s ability to differentiate normal fundus images from
those with DR.
Methods
Subject recruitment
Health, alcohol and psychosocial factors in eastern Europe
(HAPIEE): Participants of the population-based study were 45-72
year-old residents of the second largest city in Lithuania (Kaunas)
randomly drawn from the population register of the city (population of
352,000 residents). The original study was part of a prospective cohort
study on Health, Alcohol and Psychosocial Factors in Eastern Europe
(HAPIEE) [11]. A total of 7,087 individuals participated. The subjects
for ophthalmological examination were randomly drawn from the
main study and included a total of 1,065 participants; 1,014
participants (2024 eyes) had retinal images taken and these were used
for this study. The camera used in this study was a Canon CF-60Uvi
(Canon Medical Systems, USA). Informed consent was obtained from
each participant. The study was approved by regional ethics committee
and was carried out in accordance with the Declaration of Helsinki
[12].
The prevalence of age-related macular degeneration in Italy
(PAMDI): The study population was described in details elsewhere
[13], but a short summary is given below. PAMDI examined 1,162
participants between 31 Oct 2005 and 31 Oct 2006 in two communities
in North-East Italy: one of an urban district and the other one living in
two adjacent small rural communities. Inhabitants aged 60 years or
older was invited to participate in the study. A total of 885 participants
underwent full ophthalmic examination. At the examination a 30°
colour fundus photographs were taken of the posterior retina of both
eyes according to standard methods (ETDRS field 1M) using a digital
fundus camera (Topcon, Topcon Co., Tokyo, Japan). In our study all
882 participants with gradable images were used. The study was
approved by the University of Padua Human Research Ethics
Committee and was performed in accordance with the tenets of the
Declaration of Helsinki [13].
Muenster aging and retina study (MARS): The MARS is a
longitudinal study designed to identify medical, environmental and
genetic factors with implications for the pathogenesis and progression
of AMD. A total of 1,060 study participants were examined at baseline
(June 2001-October 2003, MARS-I) and during the first follow up
examination (November 2004-September 2006, MARS-II). All
participants were of Caucasian origin. In this study all patients with
gradable images (total of 909 participants) were used. Stereoscopic
digital colour photographs (30°) were taken from both eyes, centred on
the fovea (ZEISS FF 450 fundus camera, ZEISS Oberkochen,
Germany) [14]. The recruitment and research protocols were reviewed
and approved by the Institutional Review Board of the University of
Müenster, and written informed consent was obtained from all study
participants, in compliance with the Declaration of Helsinki [14,15].
Diabetic retinopathy grading
The human grading was performed by trained and certified graders
at MEHRC, London, UK. The results from human graders were used
as the standard grading reference. All grading is based on the
International Clinical Diabetic Retinopathy (ICDR) and Diabetic
Macular Edema Disease Severity scale [16]. Each patient was
categorised into no apparent DR (DR 0), mild non-proliferative DR
(NPDR) (DR 1) with microaneurysm(s) only, moderate NPDR (DR 2)
with more changes than mild NPDR but less than severe NPDR (DR
3). Severe NPDR is present with the ETDRS 4:2:1 rule: >20 intra-
retinal haemorrhages in all 4 quadrants, definite venous beading in ≥ 2
quadrant, prominent intra-retinal microvascular abnormalities
(IRMA) ≥ 1 quadrant and no signs of proliferative DR (PDR) (DR 4)
where neovascularization and/or vitreous or preretinal haemorrhages
is seen [16]. PDR is set to be a sight-threatening disease.
DAPHNE automated software
The current system is to separate images into disease/no disease
state based on detecting any potentially DR lesions on the retinal
image. The process of automatic DR system is divided into image
quality filtering, anatomical structure detections (including vessels,
macula and optic disc), lesion detections (such as white lesions,
haemorrhages and microaneurysms) and artefact detections [10]. The
flowchart for the system is shown in Figure 1.
Main input of the current system
The green channel of retinal images has been used in this current
method as it often shows higher contrast between dark objects and
their surrounding background.
Blood vessel tracking
As retinal blood vessels are the most stable features on retinal
images, reliable vessel segmentation is the prerequisite for good quality
automatic retinal image analysis. Therefore, the vessel centrelines are
firstly extracted through singular spectrum analysis [17]. Each
detected centreline point is regarded as an initial point to generate the
vessel network by measuring local information. Finally, a trace-back
mechanism is used to reconstruct the arteries and veins network as
shown in Figure 2 [10].
Citation: Hansen MB, Tang HL, Wang S, Al Turk L, Piermarocchi R, et al. (2016) Automated detection of Diabetic Retinopathy in Three
European Populations. J Clin Exp Ophthalmol 7: 582. doi:10.4172/2155-9570.1000582
Page 2 of 8
J Clin Exp Ophthalmol, an open access journal
2155-9570
Volume 7 • Issue 4 • 1000582
Figure 1. Flowchart of automated grading system, this flowchart shows the pathway for the DAPHNE software before its output.
Figure 2: A) The detected vessel centrelines B) The reconstructed
vessel network, Singular spectrum analysis extract the vessels first,
than trace-back mechanism is used to reconstruct the network.
Image quality filtering
Measuring image quality is fundamental for the automated systems
as it determines if image quality is sufficient for grading purpose using
the automated analysis. The proposed system relies on the assumption
that a normal quality image should include sufficient retinal landmarks
such as the vessel network. In this stage, a polar coordinate system is
employed to define a number of local windows. The vessels
distribution in each local window is obtained by measuring the
number of vessel centrelines in each window. The vessel centrelines are
extracted in vessel tracking stage, an example is seen in Figure 3. The
number of vessel centrelines in each local window will be regarded as a
feature to classify the quality level of the retinal images (gradable or
ungradable).
Figure 3: A polar coordinate system, the vessel centrelines are
extracted in vessel tracking stage, the number of vessel centrelines
in each local window is used to determine quality level of the retinal
images.
Sample images with quality levels graded by human experts were
first obtained. Their vessel measurements as described above were
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obtained and used for training together with grading levels.
Once the system is trained, any previous unseen image will go through
the same procedure having their vessel structure extracted and their
quality level is then predicted by the automated system. After quality
filtering the grading can take place [10].
Optic disc and macula detection
Our approach for locating the position of optic disc (OD) is by
using the vessel network, as the main retina vessels converge to the
OD.
The candidate region of macula is defined as a circular area and it is
located at about 2-disc diameter (2DD) temporal to the optic disc in
the retinal images, as shown in Figure 4. Therefore, these anatomical
constraints are used to search for a candidate macula region.
Figure 4: Optic Disc and macula detection, Vessel network determines the optic disc, than the macular is set at 2DD temporal to the disc.
Bright lesions detection
In this process, all bright regions in the image will be detected as
candidate regions. Since the optic disc has been identified in the
previous stage, it is excluded from the candidate list. For the remaining
bright regions, the means and standard deviations of different colour
channels (RGB, HIS and LUV) are extracted as the features for
classifying them as bright lesions or non-lesions through a
combination of multiple classifiers [10].
Dot haemorrhages and microaneurysms detection
Since dot haemorrhages and microaneurysms (MA) are circular
shapes, the cross-section profiles of these circular shapes play an
important role for an effective separation between them and other
objects. Candidate objects are firstly extracted and then their cross-
section profiles along multiple directions are processed. A set of
statistical features of these profiles is then extracted and refined to
separate dot haemorrhages and microaneurysms from their similar
candidate objects such as background noise, other most common
interfering objects and artefacts. The process is illustrated in Figure 5
[10].
Haemorrhages detection
While dot haemorrhages are detected together with MA detection,
other types of haemorrhages (such as elongated ones), still need to be
identified. The complexity of haemorrhage detection lies in the fact
that the shape and size of haemorrhages can vary hugely. Once retinal
blood vessels are detected (see above) as large dark objects, the
majority of blood vessels will be firstly removed and the remaining
dark objects will be classified as haemorrhages or non- haemorrhages.
Moreover, some elongated haemorrhages can be connected to vessels
as shown in Figure 6. These haemorrhages are separated from the
vessel during the vessel network tracking process [10].
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Figure 5: A) An MA B) the cross-section lines C) SSA-based cross-section profiles, Candidates of MA and haemorrhages are firstly extracted
and then their cross-section profiles, statistical features of these profiles is then extracted and refined to separate dot haemorrhages and
microaneurysms from background noise and artefacts.
Figure 6: Haemorrhage detection, once retinal blood vessels are
detected as large dark objects, the majority of blood vessels will be
firstly removed and the remaining dark objects will be classified as
haemorrhages or non- haemorrhages.
Comparison between human and automated grading
Once grading was completed independently both by human graders
and DAPHNE, a comparison between outcomes for all 3 studies were
made.
DAPHNE output gives a value of 0 for no detectable DR changes
and 1 for detectable DR; an image recognized as ungradable by the
software also gives the output of image quality 0. These can then
afterwards be converted into a value of 1 (potential detectable
retinopathy), to signify the need to be graded by a human grader. The
results from human grading was then put to equal values with every
grade from 1-4 (from the grading scale) transformed into 1 as
detectable DR and 0 for no DR changes per patient. Patient with
ungradable images is marked with a positive outcome (value 1) by
human graders as well for fair comparison to DAPHNE’s output, so if
both human and software deemed an image ungradable, it would be
classified as true positive comparison. If the software detects an image
as ungradable and the human grader detects it as gradable but with no
DR changes, this is considered a false positive outcome.
This study concentrated on DAPHNE’s ability to detect DR on
retinal images when compared to human graders. Therefore
comparison with HbA1c, DM type or other co-morbidities and DR
grading was outside of the scope of this study.
Ethical approvals
All images were anonymized before submitting to MEHRC for
grading. All studies had relevant ethical approvals and all studies
followed the Helsinki declaration.
Results
HAPIEE study (Lithuania)
In this study 1014 participants were included. Human grading from
MEHRC detected 94 referable DR cases giving a prevalence of 9.3%. A
total of 91 participants showed NPDR changes and 3 had PDR.
Humans graded 46 participants to have at least one eye ungradable due
to insufficient image quality or obscuring objects.
Reading Centre, MEH
Positive Negative Ungradable
DAPHNE
software
Positive 85 80 0 165
Negative 9 739 0 748
Ungradable 0 55 46 101
94 874 46 1014
Table 1: Results from HAPIEE study, the results of human grading and
DAPHNE software. The outcome is divided into positive, negative and
undgradable and compared between human and DAPHNE.
Table 1 shows the result from the DAPHNE software. It had a total
of 165 positive cases, 16.3% of the study population. The sensitivity
(SE) was 93.6% (95% CI, 88.1-97.0%), and specificity (SP) of 84.6%
(95% CI, 82.0-86.9%). The positive predictive value (PPV) was 49.3%
(95% CI, 43.1-55.4%) and the negative predictive value (NPV) was
98.8% (95% CI, 97.7-99.5%). Overall agreement between software and
human grading was 85.8%. The false positive rate of the DAPHNE
positive results was 48.5%.
DAPHNE declared 6.4% of all the fundus images to have
insufficient quality for automated grading.
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PAMDI study (Italy)
In the PAMDI study a total of 882 participants were included.
Human grading detected 68 referable DR cases, giving a prevalence of
7.7%. A total of 67 participants showed NPDR changes and 1 had PDR.
Humans graded 11 participants to have at least one eye ungradable due
to insufficient image quality or obscuring objects.
Table 2 shows the results from the DAPHNE software. It detected a
total of 201 positive cases, 22.8% of the study population. The SE was
97.5% (95% CI, 91.2-99.7%), SP 81.4 (95% CI, 78.6.5-84.1%). The PPV
was 34.1% (95% CI, 27.9-40.6%) and NPV 99.7% (95% CI, 98.9-100%).
Overall agreement between software and human grading was 82.9%.
The false positive rate of the DAPHNE positive results was 66.7%.
In the PAMDI study, DAPHNE found 4.2% of all the fundus images
to have insufficient quality for automated grading while human
graders graded.
Reading Centre, MEH
Positive Negative Ungradable
DAPHNE
software
Positive 67 134 0 201
Negative 1 654 1 656
Ungradable 0 15 10 25
68 803 11 882
Table 2: Results from PAMDI study, the results of human grading and
DAPHNE software. The outcome is divided into positive, negative and
undgradable and compared between human and DAPHNE.
MARS study (Germany)
In the MARS study a total of 909 participants were included.
Human grader detected 60 referable DR cases, giving a prevalence of
6.6%. A total of 57 showed non proliferative DR and 3 participants had
PDR in at least one eye. Humans graded 3 participants to have at least
one eye upgradable due to insufficient image quality or obscuring
objects.
Reading Centre, MEH
Positive Negative Ungradable
DAPHNE
software
Positive 59 153 3 215
Negative 1 689 0 690
Ungradable 0 2 0 2
60 844 3 907
Table 3: Results from MARS study, the results of human grading and
DAPHNE software. The outcome is divided into positive, negative and
undgradable and compared between human and DAPHNE.
Table 3 shows the results from the DAPHNE software. It had a total
of 217 positive cases, 23.9% of the study population. The SE was 98.4%
(95% CI, 91.5-100%), SP 81.6 (95% CI, 78.9-81.2%). The PPV was
28.6% (95% CI 22.7-35.1%) and NPV 99.9% (95% CI, 99.2-100%).
Overall agreement between software and human grading was 82.5%.
The false positive rate of the DAPHNE positive results was 71.2%.
In the MARS Study the images were taken under clinical trial
conditions and this results in a low only 0.3% of all fundus images
having insufficient quality for automated grading, this is the same
amount as declared upgradable by human graders.
ROC for the three populations
All the results from each of the three populations were used to
produce a ROC. These results are combined in Figure 7. The results of
the area under curve (AUC) for each study were as followed; Lithuania
(HAPIEE study) 0.9689, Italy (PAMDI study) 0.9731 and for Germany
(MARS study) 0.9730.
Figure 7: ROC shows the results from the three different
populations.
Discussion
This is the first time the DAPHNE software has been tested on three
different populations concurrently in order to test its ability to
function on image sets from three different countries with different
camera types and settings. It detected DR changes with SE above 93%
in all three studies with excellent NPV of above 98% in all studies
without missing sight-threatening DR in any of these studies. With
these high SE results it managed to stay above the UK guidelines for SE
in a screening setting of 80% [18], albeit on population based studies,
but for the same disease, DR, as in DR screening. There was only a
small difference in SE between the different populations, ranging from
93.6-98.4% and for NPV with an even smaller range of 98.8-99.9%. In
all three studies the overall agreement between DAPHNE software and
human grading was above 82% with impressive AUC for each of the
three populations.
Image quality is clearly important both for human and automated
grading, as the study with the lowest SE and NPV was the HAPIEE
study, that had the highest number of ungradable patients due to poor
image quality.
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The results show an overestimation of diseased retinae with higher
than expected level of false positive results with a total rate of 63%.
One reason for this is the number of images analysed to be ungradable
by the software. For each image per patient ungradable the whole
patient becomes a positive outcome as a safety for not overseeing
disease in insufficient quality images. This is a safety feature of the
current software, but admittedly it raises the number of images to be
re-graded by human graders. In the future this element should be
improved on so the automated software should mimic human graders’
workflow and allow for enough gradable area per eye to be treated as a
gradable image. Another major reason is that the software still needs to
learn identification of lesions related to other diseases mimicking DR,
such as drusen and pigmentary changes in age-related macular
degeneration (AMD), where drusen can be mistaken for exudate and
pigmentary changes might be understood as haemorrhages. Currently,
the artefact detection system works well and filters out the repeated
artefacts and so these cause less of an issue. Based on our results,
DAPHNE might be safe to use in population based studies in order to
minimise grading requirements for DR safely, as it has a good safety
profile for being able to identify completely normal images. Should
these have been screening images, no referable cases would have been
missed [19].
Nevertheless, the software would have resulted in a 70% decrease for
the number of patients needed graded by humans, assuming that only
DAPHNE positive results were seen again by humans. Even if a small
percentage of normals were to be seen by the software, DAPHNE
would have done equal to other softwares with reduction of 60% in
human grading input [5]. DAPHNE was superior in terms of reduction
of manual human workload to other softwares as those reported with a
reduction of 36.3% [20] and 48.4% [21], respectively.
The sensitivity and NPV of DAPHNE is similar to other automated
software that has been tested on a large population with a SE of 91%
and NPV of 98% [5], although that software has a higher cut-off and is
destined to find disease that is likely to become sight-threatening
requiring referral. Higher cut-off value might be more beneficial to
some country’s requirements, while for others detecting any disease
might be more meaningful, depending on capacity for shorter follow-
ups and treatment. DAPHNE shows particular strength is its high
specificity, it being above 80% in all the three populations. This is
higher than other software. Valverde et al. showed in their study a
comparison between available automated softwares and their results
on screening for DR [22]. They compared the Retinalyze System® with
SE of 97% and SP of 75% [7]. The iGradingM® works similar to
DAPHNE with “disease/no-disease”, it achieved SE of 90.5% and SP of
67.4% [23].The RetmarkerSR® achived SE of 95.8% and SP of 63.2%
[24]. In common for these other softwares are approximately the same
SE but DAPHNE showed higher SP compared to all of the other
mentioned softwares.
For population based studies, such as the three used in this study,
detecting any DR related change is essential for establishing true
estimates of the burden of disease. Hence, it is fair to say that
DAPHNE is showing promising results for determining disease/no-
disease state, but there is further work required to allow more
sophisticated sub-categorisation of the image sets.
Using automated images analysis is not the only avenue researchers
pursue for better population coverage and more refined phenotyping
of patient cohorts. Some groups worked with a combination of
automated software and analysis of tear fluid proteomics biomarkers
for detecting DR with a sensitivity/specificity of 0.93/0.78 [25,26].
These results are similar to ours although there are still methodological
issues, it might be a promising way in cases where there is no
possibility of taking images.
For the DAPHNE software to function in a real-life setting either for
population based studies or for DR screening, it still needs to be able to
identify other common eye diseases such as Age-related Macular
Degeneration (AMD) and glaucoma. This could be the next stage in
the development of fully functional retinal image analysis software.
The DAPHNE team is working on implementing the optic disc grading
tools into their software, and further testing will be carried out on this
methodology to prove its worth [27]. The DAPHNE software also
needs testing on other camera modalities such as ultra-wide-field
imaging and not just standard fundus camera.
In conclusion, the DAPHNE software showed consistently good
results for analysing DR in three different countries in Europe. Further
head-to-head comparison with other softwares and the possibly the
development of a combined algorithm taking advantage of the best
elements of all softwares might produce the safest and best quality final
DR software.
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